Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

被引:0
|
作者
Elizabeth Hovey
Paul de Souza
Gavin Marx
Phillip Parente
Tal Rapke
Andrew Hill
Antonino Bonaventura
Antony Michele
Paul Craft
Ehtesham Abdi
Andrew Lloyd
机构
[1] Prince of Wales Hospital,Department of Medical Oncology
[2] University of New South Wales,undefined
[3] University of Western Sydney,undefined
[4] Sydney Haematology Oncology Clinics,undefined
[5] Box Hill Hospital,undefined
[6] Sanofi Australia Pty Ltd,undefined
[7] Gold Coast Hospital,undefined
[8] ANZGOG,undefined
[9] Calvary Hospital,undefined
[10] The Canberra Hospital,undefined
[11] The Tweed Hospital,undefined
[12] Griffith University,undefined
来源
Supportive Care in Cancer | 2014年 / 22卷
关键词
Breast cancer; Docetaxel; Fatigue; Prostate cancer; Modafinil; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1233 / 1242
页数:9
相关论文
共 50 条
  • [21] Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial
    Freudenreich, Oliver
    Henderson, David C.
    Macklin, Eric A.
    Evins, A. Eden
    Fan, Xiaoduo
    Cather, Cori
    Walsh, Jared P.
    Goff, Donald C.
    JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (12) : 1674 - 1680
  • [22] A phase III randomized, placebo-controlled, double-blind trial of a eugeroic agent in 642 cancer patients reporting fatigue during chemotherapy: A URCC CCOP Study
    Morrow, G. R.
    Jean-Pierre, P.
    Roscoe, J. A.
    Heckler, C. E.
    Schwartzenberger, P. O.
    Giguere, J. K.
    Dakhil, S. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Masato Murakami
    Kenichi Osada
    Hiromichi Mizuno
    Toshimitsu Ochiai
    Levent Alev
    Kusuki Nishioka
    Arthritis Research & Therapy, 17
  • [24] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
  • [25] A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
    Murakami, Masato
    Osada, Kenichi
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Alev, Levent
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [26] Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study
    Dackis, CA
    Lynch, KG
    Yu, E
    Samaha, FF
    Kampman, KM
    Cornish, JW
    Rowan, A
    Poole, S
    White, L
    O'Brien, CP
    DRUG AND ALCOHOL DEPENDENCE, 2003, 70 (01) : 29 - 37
  • [27] MODAFINIL FOR CLOZAPINE-TREATED SCHIZOPHRENIA PATIENTS. A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Freudenreich, Oliver
    Henderson, D. C.
    Macklin, E. A.
    Evins, A. E.
    Fan, X.
    Cather, C.
    Walsh, J. P.
    Goff, D. C.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 358 - 358
  • [28] Randomized, Placebo-Controlled, Double-Blind, Phase II Study of Axitinib Plus Docetaxel Versus Docetaxel Plus Placebo in Patients With Metastatic Breast Cancer
    Rugo, Hope S.
    Stopeck, Alison T.
    Joy, Anil A.
    Chan, Stephen
    Verma, Shailendra
    Lluch, Anna
    Liau, Katherine F.
    Kim, Sinil
    Bycott, Paul
    Rosbrook, Brad
    Bair, Angel H.
    Soulieres, Denis
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18) : 2459 - 2465
  • [29] Quality of life in plaque psoriasis patients treated with voclosporin: a Canadian phase III, randomized, multicenter, double-blind, placebo-controlled study
    Kunynetz, Rod
    Carey, Wayne
    Thomas, Richard
    Toth, Darryl
    Trafford, Ted
    Vender, Ronald
    EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (01) : 89 - 94
  • [30] Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy
    Yoshimasa Kosaka
    Yoshiaki Rai
    Norikazu Masuda
    Toshimi Takano
    Toshiaki Saeki
    Seigo Nakamura
    Ryutaro Shimazaki
    Yoshinori Ito
    Yutaka Tokuda
    Kazuo Tamura
    Supportive Care in Cancer, 2015, 23 : 1137 - 1143